Skip to main content

09-13-2018 | Pramlintide acetate | Article

Control of postprandial hyperglycemia in type 1 diabetes by 24-hour fixed-dose coadministration of pramlintide and regular human insulin: A randomized, two-way crossover study

Riddle MC et al. Diabetes Care 2018: dc181091. doi: 10.2337/dc18-1091

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics